Source: International Congress 2015 – Outcomes of lung transplantation
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Abdul Monem Hamid (Puteaux, France), Am Hamid, A. Roux, O. Boche, J. Leport, M. Stern, S. De Miranda, D. Grenet, L. Azuar-Beaumont, B. Douvry, D. Usturoi, E. Cuquemelle, E. Sage, A. Chapelier, C. Picard. Anti-reflux surgery for gastroesophageal reflux disease after lung transplantation: Benefit for lung function, acute rejections and respiratory infections. Eur Respir J 2015; 46: Suppl. 59, 4543

Member's Comments

No comment yet.

Related content which might interest you: Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection Source: Eur Respir J 2008; 31: 707-713 Year: 2008 Pulmonary function and respiratory complications in hematopoietic cell transplant Source: International Congress 2016 – Quality and quantity in lung function Year: 2016 Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life Source: Eur Respir J 2012; 39: 691-697 Year: 2012 Is lung transplantation still indicated? Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema Year: 2006 The burden of sinus disease in CF candidates for lung transplantation Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 CF sinus disease after lung transplantation Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 The relationship between gastro-oesophageal reflux and bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009 Surgical treatment of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=359 Year: 2006 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Interstitial lung disease caused by designer drugs Source: International Congress 2015 – A morphological view of chest pathology Year: 2015 Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004 Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans Source: International Congress 2016 – Orphan diseases I Year: 2016 Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease Source: International Congress 2016 – Sarcoidosis Year: 2016 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015